8,978 Shares in Integer Holdings Co. (NYSE:ITGR) Bought by Cubist Systematic Strategies LLC

Posted by Defense World Staff on Mar 13th, 2023

Cubist Systematic Strategies LLC bought a new position in Integer Holdings Co. (NYSE:ITGR – Get Rating) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 8,978 shares of the medical equipment provider’s stock, valued at approximately $559,000.

A number of other institutional investors also recently bought and sold shares of the stock. MML Investors Services LLC raised its holdings in Integer by 4.3% in the 3rd quarter. MML Investors Services LLC now owns 5,077 shares of the medical equipment provider’s stock worth $316,000 after purchasing an additional 210 shares during the period. Nuveen Asset Management LLC raised its holdings in Integer by 3.6% in the 3rd quarter. Nuveen Asset Management LLC now owns 219,758 shares of the medical equipment provider’s stock worth $13,675,000 after purchasing an additional 7,694 shares during the period. AXA S.A. raised its holdings in Integer by 45.9% during the third quarter. AXA S.A. now owns 52,400 shares of the medical equipment provider’s stock valued at $3,260,000 after acquiring an additional 16,475 shares during the period. Shell Asset Management Co. raised its holdings in Integer by 4.0% during the third quarter. Shell Asset Management Co. now owns 4,521 shares of the medical equipment provider’s stock valued at $281,000 after acquiring an additional 172 shares during the period. Finally, Hsbc Holdings PLC raised its holdings in Integer by 77.1% during the third quarter. Hsbc Holdings PLC now owns 8,121 shares of the medical equipment provider’s stock valued at $516,000 after acquiring an additional 3,536 shares during the period. 98.42% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Piper Sandler assumed coverage on Integer in a report on Friday, February 24th. They set an “overweight” rating and a $85.00 price target on the stock. KeyCorp raised their price target on Integer from $84.00 to $86.00 and gave the company an “overweight” rating in a report on Thursday, February 9th.

Insider Activity

In other news, CEO Joseph W. Dziedzic acquired 4,000 shares of the business’s stock in a transaction dated Friday, December 16th. The stock was purchased at an average price of $61.95 per share, for a total transaction of $247,800.00. Following the completion of the transaction, the chief executive officer now directly owns 122,378 shares in the company, valued at approximately $7,581,317.10. The acquisition was disclosed in a filing with the SEC, which is available through this link. Company insiders own 2.01% of the company’s stock.

Integer Trading Down 2.1 %

Shares of Integer stock opened at $73.14 on Monday. The firm has a market cap of $2.43 billion, a price-to-earnings ratio of 36.94 and a beta of 1.11. The business has a 50-day moving average price of $72.64 and a 200-day moving average price of $67.55. The company has a quick ratio of 1.56, a current ratio of 2.50 and a debt-to-equity ratio of 0.65. Integer Holdings Co. has a twelve month low of $50.05 and a twelve month high of $88.58.

Integer (NYSE:ITGR – Get Rating) last issued its quarterly earnings data on Thursday, February 16th. The medical equipment provider reported $1.11 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.06. The firm had revenue of $372.42 million during the quarter, compared to analyst estimates of $371.00 million. Integer had a return on equity of 9.42% and a net margin of 4.82%. The business’s quarterly revenue was up 19.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.99 earnings per share. Equities research analysts anticipate that Integer Holdings Co. will post 4.12 EPS for the current fiscal year.

Integer Profile

(Get Rating)

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies.